Cas:83229-23-6 8-chloro-3,4-dihydro-1H-quinolin-2-one manufacturer & supplier

Chemical Name:8-chloro-3,4-dihydro-1H-quinolin-2-one

CAS.NO:83229-23-6

Synonyms:8-chloro-1,2,3,4-tetrahydroquinolin-2-one;8-chloro-3,4-dihydrocarbostyril;8-Chlor-3,4-dihydro-1H-chinolin-2-on

Molecular Formula:C₉H₈ClNO

Molecular Weight:181.61900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:32.59000

Exact Mass:181.02900

LogP:2.30980

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 8-chloro-1,2,3,4-tetrahydroquinolin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-Chlor-3,4-dihydro-1H-chinolin-2-on physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-chloro-3,4-dihydrocarbostyril Use and application,8-Chlor-3,4-dihydro-1H-chinolin-2-on technical grade,usp/ep/jp grade.

Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. 8-chloro-3,4-dihydro-1H-quinolin-2-one manufacturer Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 8-chloro-3,4-dihydro-1H-quinolin-2-one supplier The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week. 8-chloro-3,4-dihydro-1H-quinolin-2-one vendor Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. 8-chloro-3,4-dihydro-1H-quinolin-2-one factory The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.